Clinical Trial: A Multicentre Prospective Cohort Study: Intensive Adjuvant Therapy for TNBC With BRCA Gene Mutation

U.S., May 8 -- ClinicalTrials.gov registry received information related to the study (NCT06405295) titled 'A Multicentre Prospective Cohort Study: Intensive Adjuvant Therapy for TNBC With BRCA Gene Mutation' on May 4.

Brief Summary: Evaluation of the efficacy and safety of different adjuvant intensification regimens in early-stage BRCA1/2 mutant triple-negative breast cancer.

Study Type: Observational

Condition: Early-stage Triple-negative Breast Cancer With BRCA1/2 Mutations

Intervention: Other: no intervention

Observation of the prognosis of patients with different standard treatment protocols in the clinic without intervention

Recruitment Status: Not Yet Recruiting

Published by HT Digital Content Services with permission from Heal...